Knyihár-Csillik E, Tajti J, Chadaide Z, Csillik B, Vécsei L
Department of Neurology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, H-6701 Szeged, Hungary.
Microsc Res Tech. 2001 May 1;53(3):193-211. doi: 10.1002/jemt.1084.
The supratentorial cerebral dura of the albino rat is equipped with a rich sensory innervation both in the connective tissue and around blood vessels, which includes nociceptive axons and their terminals; these display intense calcitonin gene-related peptide (CGRP) immunoreactivity. Stereotactic electrical stimulation of the trigeminal (Gasserian) ganglion, regarded as an experimental migraine model, caused marked increase and disintegration of club-like perivascular CGRP-immunopositive nerve endings in the dura mater and induced an apparent increase in the lengths of CGRP-immunoreactive axons. Intravenous administration of sumatriptan or eletriptan, prior to electrical stimulation, prevented disintegration of perivascular terminals and induced accumulation of CGRP in terminal and preterminal portions of peripheral sensory axons. Consequently, immunopositive terminals and varicosities increased in size; accumulation of axoplasmic organelles resulted in the "hollow" appearence of numerous varicosities. Since triptans exert their anti-migraine effect by virtue of agonist action on 5-HT(1D/B) receptors, we suggest that these drugs prevent the release of CGRP from perivascular nerve terminals in the dura mater by an action at 5-HT(1D/B) receptors. Nitroglycerine (NitroPOHL), given subcutaneously to rats, induces increased beading of nitric oxide synthase (NOS)-immunoreactive nerve fibers in the supratentorial cerebral dura mater, and an apparent increase in the number of NOS-immunoreactive nerve fibers in the dural areas supplied by the anterior and middle meningeal arteries, and the sinus sagittalis superior. Structural alterations of nitroxidergic axons innervating blood vessels of the dura mater support the idea that nitric oxide (NO) is involved in the induction of headache, a well-known side effect of coronary dilator agents.
白化大鼠幕上脑硬膜在结缔组织和血管周围均有丰富的感觉神经支配,其中包括伤害性轴突及其终末;这些轴突和终末显示出强烈的降钙素基因相关肽(CGRP)免疫反应性。将三叉神经(半月神经节)节的立体定向电刺激视为实验性偏头痛模型,该刺激导致硬脑膜中棒状血管周围CGRP免疫阳性神经终末明显增加和崩解,并使CGRP免疫反应性轴突的长度明显增加。在电刺激前静脉注射舒马曲坦或依立曲坦,可防止血管周围终末崩解,并诱导CGRP在外周感觉轴突的终末和终末前部分蓄积。因此,免疫阳性终末和曲张体尺寸增大;轴浆细胞器的蓄积导致许多曲张体呈现“中空”外观。由于曲坦类药物通过对5-HT(1D/B)受体的激动作用发挥其抗偏头痛效应,我们认为这些药物通过作用于5-HT(1D/B)受体来阻止CGRP从硬脑膜血管周围神经终末释放。皮下给予大鼠硝酸甘油(NitroPOHL),可诱导幕上脑硬膜中一氧化氮合酶(NOS)免疫反应性神经纤维的串珠样增加,并使由脑膜前动脉、脑膜中动脉和上矢状窦供血的硬脑膜区域中NOS免疫反应性神经纤维数量明显增加。支配硬脑膜血管的含氮氧化物能轴突的结构改变支持了一氧化氮(NO)参与头痛诱导的观点,头痛是冠状动脉扩张剂的一种众所周知的副作用。